perindopril has been researched along with Disease Exacerbation in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (58.62) | 29.6817 |
| 2010's | 11 (37.93) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Abo-Youssef, AM; Ali, MRA; Khattab, MM; Messiha, BAS | 1 |
| Bourke, JP; Bueser, T; Quinlivan, R | 1 |
| Sharma, K; Sweiss, N | 1 |
| de Feyter, PJ; Gijsen, FJ; Regar, E; Rodriguez-Granillo, G; Schuurbiers, JC; van der Giessen, R; van der Steen, AF; Wentzel, JJ | 1 |
| Agmadova, ZM; Kallaeva, AN | 1 |
| Borghi, C; Cicero, AF; Morbini, M | 1 |
| Nakka, S; Patel, SS | 1 |
| Chalmers, J; Harrap, S; Li, Q; Marre, M; Mohammedi, K; Patel, A; Woodward, M; Zoungas, S | 1 |
| Anderson, C; Bousser, MG; Chalmers, J; Coskun, O; Dufouil, C; Godin, O; MacMahon, S; Mazoyer, B; Tzourio, C; Tzourio-Mazoyer, N | 1 |
| Ceconi, C; Ferrari, R; Guardigli, G | 1 |
| Gapon, LI | 1 |
| Chalmers, J; Colagiuri, S; Grobbee, DE; Hamet, P; Heller, S; Kengne, AP; Lievre, M; Marre, M; Neal, B; Patel, A; Travert, F; Woodward, M; Zoungas, S | 1 |
| Koya, D | 1 |
| Gilbert, RE; Kelly, DJ; Koji, T; Maguire, J; Stein-Oakley, A; Thomson, N; Wassef, L; Wilkinson-Berka, JL; Zhang, Y | 1 |
| Chalmers, J; Hasegawa, Y; Omae, T; Woodward, M; Yamaguchi, T | 1 |
| Allen, TJ; Campbell, DJ; Cooper, ME; Gilbert, RE; Hammond, JJ; Jerums, G; O'Brien, RC; Raffaele, J; Tsalamandris, C | 1 |
| Bécane, HM; Devaux, JY; Duboc, D; Lerebours, G; Meune, C; Vaksmann, G | 1 |
| Sanders, SP | 1 |
| Eliseev, OM | 1 |
| Besançon, V; Bousser, MG; Chalmers, J; Coskun, O; Dufouil, C; Guillon, P; MacMahon, S; Mazoyer, B; Neal, B; Tzourio, C; Tzourio-Mazoyer, N; Woodward, M | 1 |
| Schiffrin, EL | 1 |
| Hirano, M | 1 |
| Fujimoto, M; Fukui, H; Ikenaka, Y; Kaji, K; Kitade, M; Kojima, H; Mitoro, A; Noguchi, R; Toyohara, M; Uemura, M; Yamao, J; Yamazaki, M; Yoshiji, H | 1 |
| Bertrand, M; Bruining, N; De Feyter, PJ; de Winter, S; Deckers, JW; Ferrari, R; Fox, KM; Garcia-Garcia, HM; Ligthart, JM; Remme, W; Rodriguez-Granillo, GA; Simoons, ML; Vos, J | 1 |
| Schoenhagen, P; Sipahi, I | 1 |
| Bruining, N; de Feyter, PJ; de Winter, S; García-García, HM; Ligthart, JM; Rodriguez-Granillo, GA; Valgimigli, M | 1 |
| Remme, WJ | 1 |
| Cooper, ME; Gibbs, NJ; Kelly, DJ; Skinner, SL; Wilkinson-Berka, JL | 1 |
| Allen, TJ; Burns, WC; Candido, R; Cao, Z; Cooper, ME; Dilley, RJ; Jandeleit-Dahm, KA; Nesteroff, SP; Twigg, SM | 1 |
6 review(s) available for perindopril and Disease Exacerbation
| Article | Year |
|---|---|
Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.
Topics: Adolescent; Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiovascular Agents; Child; Disease Progression; Eplerenone; Human Growth Hormone; Humans; Lisinopril; Losartan; Male; Muscular Dystrophy, Duchenne; Non-Randomized Controlled Trials as Topic; Perindopril; Placebos; Randomized Controlled Trials as Topic; Stroke Volume; Ubiquinone; Young Adult | 2018 |
Adiponectin effects on the kidney.
Topics: Adiponectin; Albuminuria; Amlodipine; AMP-Activated Protein Kinases; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Humans; Kidney; Kidney Diseases; Mice; Obesity; Oxidative Stress; Perindopril; Renal Insufficiency, Chronic; Telmisartan | 2014 |
Combination therapy in the extended cardiovascular continuum: a focus on perindopril and amlodipine.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Disease Progression; Drug Combinations; Humans; Hypertension; Perindopril | 2015 |
Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.
Topics: Acute Coronary Syndrome; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Atherosclerosis; Bradykinin; Cardiotonic Agents; Coronary Artery Disease; Disease Progression; Endothelial Cells; Endothelium, Vascular; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Perindopril; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Secondary Prevention; Stem Cells | 2010 |
Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Brain Diseases; Disease Progression; Humans; Magnetic Resonance Imaging; Perindopril; Randomized Controlled Trials as Topic; Stroke | 2005 |
Beta blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carbazoles; Carvedilol; Defibrillators, Implantable; Disease Progression; Enalapril; Heart Failure; Humans; Perindopril; Propanolamines; Treatment Outcome; Ventricular Remodeling | 2007 |
11 trial(s) available for perindopril and Disease Exacerbation
| Article | Year |
|---|---|
Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diagnostic Techniques, Cardiovascular; Disease Progression; Drug Combinations; Female; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Perindopril; Pulse; Risk Factors; Stroke | 2016 |
Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Brain; Cerebrovascular Disorders; Cognition Disorders; Dementia; Disease Progression; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Perindopril; Predictive Value of Tests; Recurrence; Stroke | 2009 |
Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Asia; Australasia; Blood Glucose; Canada; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Disease Progression; Diuretics; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; Humans; Incidence; Indapamide; Male; Middle Aged; Models, Cardiovascular; Perindopril; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors | 2011 |
[Lowering blood pressure and glucose reduces renal events in type 2 diabetes; ADVANCE study].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Diuretics; Humans; Indapamide; Perindopril | 2010 |
Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Brain; Cerebral Infarction; Diastole; Disease Progression; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Indapamide; Japan; Male; Middle Aged; Perindopril; Secondary Prevention; Stroke; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Perindopril; Prospective Studies | 2004 |
Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Child; Child Welfare; Disease Progression; Double-Blind Method; Follow-Up Studies; Humans; Muscular Dystrophy, Duchenne; Perindopril; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2005 |
[Dynamic results of the EUROPA study: mechanisms of a favourable influence of perindopril on the course of IHD and decreased IHD mortality].
Topics: Angiotensin-Converting Enzyme Inhibitors; Disease Progression; Endothelium, Vascular; Humans; Myocardial Ischemia; Perindopril; Survival Rate; Ultrasonography | 2005 |
Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Disease Progression; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Male; Middle Aged; Perindopril; Transforming Growth Factor beta | 2006 |
Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study).
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Angiography; Coronary Artery Disease; Disease Progression; Endosonography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Perindopril; Prospective Studies | 2007 |
Effect of perindopril on coronary remodelling: insights from a multicentre, randomized study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Observer Variation; Perindopril; Regression Analysis; Treatment Outcome; Ultrasonography, Interventional; Ventricular Remodeling | 2007 |
12 other study(ies) available for perindopril and Disease Exacerbation
| Article | Year |
|---|---|
Perindopril ameliorates experimental Alzheimer's disease progression: role of amyloid β degradation, central estrogen receptor and hyperlipidemic-lipid raft signaling.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin-Converting Enzyme Inhibitors; Animals; Cognitive Dysfunction; Disease Models, Animal; Disease Progression; Female; Hyperlipidemias; Insulysin; Membrane Microdomains; Neprilysin; Perindopril; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Signal Transduction | 2020 |
Positive remodeling at 3 year follow up is associated with plaque-free coronary wall segment at baseline: a serial IVUS study.
Topics: Coronary Artery Disease; Disease Progression; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multicenter Studies as Topic; Perindopril; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Risk Factors; Ultrasonography, Interventional | 2014 |
[Special characteristics of progression of myocardial remodeling in patients with various forms of unstable angina].
Topics: Aged; Angina, Unstable; Aspirin; Benzopyrans; Cardiovascular Agents; Disease Progression; Drug Therapy, Combination; Echocardiography, Doppler; Ethanolamines; Female; Heart Failure; Humans; Male; Middle Aged; Nebivolol; Outcome Assessment, Health Care; Perindopril; Platelet Aggregation Inhibitors; Prognosis; Severity of Illness Index; Simvastatin; Time Factors; Ventricular Remodeling | 2014 |
Protective Effect of Perindopril on Tumor Progression and Angiogenesis in Animal Model of Breast Cancer.
Topics: Angiogenesis Inhibitors; Angiotensin-Converting Enzyme Inhibitors; Animals; Breast; Breast Neoplasms; Chick Embryo; Chickens; Cornea; Disease Models, Animal; Disease Progression; Female; Neovascularization, Pathologic; Perindopril; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2017 |
[Angiotensin converting enzyme inhibitor perindopril in the treatment of patients with arterial hypertension and renal failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cerebrovascular Disorders; Disease Progression; Drug Dosage Calculations; Humans; Hypertension, Renal; Kidney Function Tests; Monitoring, Physiologic; Perindopril; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2010 |
Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: attenuation with renin-angiotensin blockade.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Fas Ligand Protein; fas Receptor; Female; Membrane Glycoproteins; Perindopril; Rats | 2004 |
Did they lower stress in the trial? Or was it just wasted energy?
Topics: Angiotensin-Converting Enzyme Inhibitors; Disease Progression; Humans; Muscular Dystrophy, Duchenne; Perindopril; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 2005 |
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Brain; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Treatment Outcome | 2005 |
Does ACE inhibitor therapy delay onset and progression of cardiac dysfunction in duchenne muscular dystrophy?
Topics: Adrenal Cortex Hormones; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathies; Child; Disease Progression; Humans; Multicenter Studies as Topic; Muscular Dystrophy, Duchenne; Perindopril; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome | 2006 |
Arterial remodelling: an independent pathophysiological component of atherosclerotic disease progression and regression. Insights from serial pharmacological intervention trials.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Disease Progression; Humans; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Treatment Outcome | 2007 |
Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Female; Heterozygote; Kidney; Perindopril; Rats; Renin; Tetrazoles; Valine; Valsartan | 2001 |
Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice.
Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Collagen; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Disease Progression; Growth Substances; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Perindopril; Phagocytes; Proliferating Cell Nuclear Antigen; RNA, Messenger; Vascular Cell Adhesion Molecule-1 | 2002 |